These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11399252)

  • 1. Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.
    Gourine A; Gonon A; Sjöquist PO; Pernow J
    Cardiovasc Res; 2001 Jul; 51(1):100-7. PubMed ID: 11399252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.
    Gourine AV; Pernow J; Poputnikov DM; Sjöquist PO
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):564-70. PubMed ID: 12352318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Nordlander M; Rydén L
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):338-43. PubMed ID: 10975591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
    Gonon AT; Gourine AV; Pernow J
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):405-12. PubMed ID: 10975600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
    Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Rydén L
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):339-45. PubMed ID: 12198319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
    Pernow J; Wang QD
    Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.
    Schulz R; Wambolt R
    Cardiovasc Res; 1995 Sep; 30(3):432-9. PubMed ID: 7585835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine.
    Wang QD; Hemsén A; Li XS; Lundberg JM; Uriuda Y; Pernow J
    Cardiovasc Res; 1995 Jan; 29(1):44-9. PubMed ID: 7895238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
    Jung C; Gonon AT; Sjöquist PO; Lundberg JO; Pernow J
    Cardiovasc Res; 2010 Jan; 85(1):147-54. PubMed ID: 19726439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
    Gourine AV; Gonon AT; Pernow J
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1105-12. PubMed ID: 11179053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.
    Odenstedt J; Månsson C; Grip L
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):407-15. PubMed ID: 15454848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig.
    Pernow J; Uriuda Y; Wang QD; Li XS; Nordlander R; Rydeén L
    Eur Heart J; 1994 Dec; 15(12):1712-9. PubMed ID: 7698143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part I.
    Wang QD; Segawa D; Ericsson H; Sjöquist PO; Johansson L; Rydén L
    J Cardiovasc Pharmacol; 2002 Aug; 40(2):228-34. PubMed ID: 12131552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective activity of endogenous and exogenous nitric oxide on ischaemia reperfusion injury in isolated guinea pig hearts.
    Masini E; Salvemini D; Ndisang JF; Gai P; Berni L; Moncini M; Bianchi S; Mannaioni PF
    Inflamm Res; 1999 Nov; 48(11):561-8. PubMed ID: 10598011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion.
    Gonon AT; Gourine AV; Middelveld RJ; Alving K; Pernow J
    Basic Res Cardiol; 2001 Sep; 96(5):454-62. PubMed ID: 11605992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.